Position in MDXG
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,628,761
+$223,743 QoQ
Shares Held
423,055
+18.9% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. MDXG ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,628,761 | 423,055 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,405,018 | 355,701 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,530,618 | 373,799 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,494,661 | 500,668 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $3,040,934 | 497,698 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,766,864 | 495,640 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $4,848,546 | 504,007 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,959,177 | 500,707 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,836,753 | 409,344 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,881,624 | 374,237 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,518,470 | 401,194 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,092,569 | 424,221 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,617,004 | 395,916 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,372,991 | 402,637 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,128,501 | 405,936 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $1,157,570 | 403,335 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,317,842 | 379,782 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,862,027 | 395,335 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $2,422,353 | 401,052 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $2,617,949 | 432,005 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $5,064,222 | 404,814 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,393,785 | 135,319 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,334,323 | 146,952 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||